Company profile for Flexion Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. We embrace a philosophy of scientific entrepreneurship which spurs innovation and empowers and inspires our people to discover, develop and commercialize transformative t...
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. We embrace a philosophy of scientific entrepreneurship which spurs innovation and empowers and inspires our people to discover, develop and commercialize transformative therapies which can make a meaningful difference in the lives of patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10 Mall Road, Suite 301, Burlington, MA 01803
Telephone
Telephone
781.305.7777
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/after-buying-out-flexion-for-450m-pacira-quietly-laid-off-110-of-its-employees/

P. Schloesser ENDPTS
04 Mar 2022
Pacira buys Flexion for $450M to boost pain offerings
Pacira buys Flexion for $450M to boost pain offerings

12 Oct 2021

// Angus Liu FIERCEPHARMA

https://www.fiercepharma.com/pharma/pacira-boosts-non-opioid-pain-portfolio-via-450m-flexion-buy-more-cvr-payments-to-come

Angus Liu FIERCEPHARMA
12 Oct 2021
Supernus and Pacira swoop while their targets are down
Supernus and Pacira swoop while their targets are down

11 Oct 2021

// Madeleine Armstrong EVALUATE

https://www.evaluate.com/vantage/articles/news/deals/supernus-and-pacira-swoop-while-their-targets-are-down

Madeleine Armstrong EVALUATE
11 Oct 2021

https://www.globenewswire.com/news-release/2021/10/01/2307364/29848/en/Flexion-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
01 Oct 2021

https://www.globenewswire.com/news-release/2021/09/02/2290770/29848/en/Flexion-Therapeutics-Announces-Inclusion-of-ZILRETTA-in-American-Academy-of-Orthopaedic-Surgeons-AAOS-Clinical-Practice-Guidelines-for-the-Management-of-Osteoarthritis-of-the-Knee.html

GLOBENEWSWIRE
02 Sep 2021

https://www.globenewswire.com/news-release/2021/08/25/2286225/29848/en/Flexion-Therapeutics-Announces-Expansion-of-Phase-1b-Trial-Investigating-FX301-for-the-Management-of-Post-Operative-Pain.html

GLOBENEWSWIRE
25 Aug 2021

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty